Long Term Follow-Up of Traumatic Fracture Patients Treated With Integrated Complementary and Alternative Medicine: Observational Study

Sponsor
Jaseng Medical Foundation (Other)
Overall Status
Completed
CT.gov ID
NCT04855058
Collaborator
(none)
665
1
9.1
73.1

Study Details

Study Description

Brief Summary

The purpose of this study is to reveal the effectiveness of integrative Korean medicine for trauma fracture by observation inpatients treated with integrative Korean medicine.

This study is a prospective observational study. The subjects for study are patients diagnosed with fracture and who have been admitted to five Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, Bundang and Haeundae) for 2017.03-2020.08.

Medical records of selected patients will be analyzed, and online google surveys(or telephone) will be conducted for each patient. The survey questions are Numeric rating scale (NRS), quality of life, and Patient Global Impression of Change (PGIC), etc.

Condition or Disease Intervention/Treatment Phase
  • Other: online survey(or phone survey)

Study Design

Study Type:
Observational
Actual Enrollment :
665 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Long Term Follow-Up of Traumatic Fracture Patients Treated With Integrated Complementary and Alternative Medicine: Observational Study
Actual Study Start Date :
Mar 29, 2021
Actual Primary Completion Date :
Aug 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Outcome Measures

Primary Outcome Measures

  1. Change from Baseline Numeric rating scale(NRS) to longterm f/u survey [baseline(admission), week 1, 2, 3, 4, 5, 6, 7, day of Discharge(up to week 8), finish f/u survey by June 2021]

    NRS uses an 11-point scale to evaluate current neck pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.

Secondary Outcome Measures

  1. The five level version of EuroQol-5 Dimension (EQ-5D) [baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021]

    EQ-5D is most widely used as a method of indirectly calculating the quality of life from various aspects. The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about) In this study, the validated Korean version questionnaire will be used

  2. Oswestry disability index (ODI) [baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021]

    The ODI is a 10-item questionnaire developed to evaluate the degree of disability for low back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. We will conduct an validated Korean ODI questionnaire(to L-SPINE, T-SPINE and sacrum fracture)

  3. Neck Disability Index (NDI) [baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021]

    NDI is a 10-item questionnaire developed to evaluate the degree of disability for neck back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. We will conduct an validated Korean NDI questionnaire (to C-SPINE fracture)

  4. Shoulder Pain and Disability Index (SPADI) [baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021]

    The Shoulder Pain and Disability Index (SPADI) is a patient completed questionnaire with 13 items assessing pain level and extent of difficulty with ADLs requiring the use of the upper extremities. The pain subscale has 5-items and the Disability subscale has 8-items. We will conduct an validated Korean SPADI questionnaire (to shoulder fracture)

  5. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) [baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021]

    WOMAC is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints. The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). We will conduct an validated Korean WOMAC questionnaire. (to knee fracture)

  6. Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH) [at finish f/u survey by June 2021]

    The DASH, an instrument that evaluates upper ex- tremity disabilities, has advantages for analyzing the overall function of the upper extremity. The 30 items in the questionnaire ask about different upper extremity disabilities in terms of symptoms, physical functions, social functions, and psychological problems. A shorter version of DASH, known as Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH), consists of 11 items from the original DASH. We will conduct an validated Korean Quick DASH questionnaire. (to clavicle, arm and hand fracture)

  7. the Hip Disability and Osteoarthritis Outcome Score(HOOS) [at finish f/u survey by June 2021]

    HOOS is developed as an instrument to assess the patients' opinion about their hip and associated problems. HOOS consists of 5 subscales; Pain, other Symptoms, Function in dailyliving (ADL). Standardized answer options are given and each question gets a score from 0 to 4. A normalized score(100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The result can be plotted as an outcome profile. We will conduct an validated Korean HOOS questionnaire.(to hip joint , ilium, ischium, and pubis fracture)

  8. the Foot Function Index (FFI) [at finish f/u survey by June 2021]

    The FFI was developed to measure the effect of foot problems on function in terms of pain and disability. The FFI is a self-administered index consisting of 23 items divided into 3 scales(limitation, pain, and disability). Korean FFI questionnaire was validated in only 2 scales(pain, disability), and we use only pain scale of FFI (to ankle and foot fracture).

  9. Symptoms of RIB,STERNUM fracture [at finish f/u survey by June 2021]

    There is no validated worldwide used questionnaire. so we use 4 questions about symptoms associated with rib and sternum fracture, based on previous article. (pain during deep breathing, coughing, turning over the body, and sleeping)

  10. Patient Global Impression of Change (PGIC) [at finish f/u survey by June 2021]

    PGIC is an indicator that evaluates the improvement of patients in 7 steps, and the subject responds with improvement of functional limitation after treatment with 7 likert. (1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse).

  11. hanbangchilyo manjogdo (Satisfaction with integrative Korean medicine) [at finish f/u survey by June 2021]

    5 answer options are given: very satisfied, a little satisfied, moderate, a little dissatisfied, very dissatisfied

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. 19-85 years old

  2. Pateints who have been admitted to five Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, Bundang and Haeundae) and hospitalized 5 days or more

  3. fracture caused by trauma

  4. Patients have agreed to participate the study.

Exclusion Criteria:
  1. pathological fracture, stress fracture

  2. Open fracture

  3. The cause of pain is due to other disease, not the fracture: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.

  4. Patients who are difficult to complete the research questionaire because of communication, mental or physical capabilities.

  5. lack of data of collection

  6. Patients deemed unable to participate in the clinical research by other researchers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jaseng Medical Foundation Seoul-si Korea, Republic of

Sponsors and Collaborators

  • Jaseng Medical Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
In-Hyuk Ha, KMD, Director, Jaseng Medical Foundation
ClinicalTrials.gov Identifier:
NCT04855058
Other Study ID Numbers:
  • JS-CT-2020-15
First Posted:
Apr 22, 2021
Last Update Posted:
Feb 8, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by In-Hyuk Ha, KMD, Director, Jaseng Medical Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022